$2.75
0.05[1.85%]
At close: May 14
$2.75
0[0.00%]
After Hours: 4:18PM EDT
Acasti Pharma
(NASDAQ:ACST)Latest News for Acasti Pharma Stock (NASDAQ:ACST)
Acasti Pharma Stock (NASDAQ: ACST)
Categories: All
Monday, February 12, 2024
Wednesday, February 07, 2024
Thursday, February 01, 2024
Thursday, January 18, 2024
Monday, October 23, 2023
Friday, October 06, 2023
Thursday, September 28, 2023
Tuesday, September 26, 2023
- Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 26, 2023, 12:56PM
- Why Acasti Pharma (ACST) Stock Is Exploding HigherHenry Khederian - Sep 26, 2023, 10:57AM
- Acasti Pharma shares are trading higher after the company announced $7.5 million in private placement equity financing.Benzinga Newsdesk - Sep 26, 2023, 10:27AM
- Acasti Announces $7.5M Private Placement Equity FinancingBill Haddad - Sep 26, 2023, 8:01AM
Wednesday, August 09, 2023
Monday, July 10, 2023
Friday, July 07, 2023
Wednesday, July 05, 2023
- Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jul 5, 2023, 1:28PM
- Acasti Announces Alignment With FDA On GTX-104 Pivotal Phase 3 Safety Trial Protocol And Confirms Planned Initiation Of STRIVE-ON In aSAH Patients In Calendar Q4 2023Benzinga Newsdesk - Jul 5, 2023, 9:03AM
Friday, June 23, 2023
Tuesday, April 04, 2023
Wednesday, February 15, 2023
Tuesday, February 14, 2023
Monday, February 13, 2023
Wednesday, January 25, 2023
Tuesday, January 17, 2023
Friday, January 06, 2023
Thursday, January 05, 2023
Wednesday, December 28, 2022
- Acasti Pharma shares are trading higher after the company announced preliminary topline results met all outcome measures in the pharmacokinetic bridging study for GTX-102, the company's drug candidate for the treatment of Ataxia Telangiectasia.Benzinga Newsdesk - Dec 28, 2022, 8:19AM
- Acasti Announces Preliminary Topline Results Met All Outcome Measures In Pharmacokinetic Bridging Study For GTX-102, The Company's Drug Candidate For Treatment Of Ataxia TelangiectasiaBill Haddad - Dec 28, 2022, 8:05AM